Welcome to WordPress. This is your first post. Edit or delete it, then start writing ..read more

..read more

..read more

..read more

It was great to to meet some new faces You might have heard about our office in LA (or not, which is okay too, but not really, so read about it). On June 5th, we hosted our first Dribbble meetup, a gathering of sorts with other designers. Dribbble is a community designers use to showcase work. We’ve already written about it here. The experience of being the first designer at Ueno LA comes with a ton of excitement, but it also brings a level of anxiety that I hadn’t ever felt before. Transitioning Green field in North of France “A possible off-the-wall idea or solution appears like a blip and ..read more

Around 40 percent of children with an uncommon disorder had 50 percent fewer seizures while taking the marijuana derivativ Cannabidiol, a compound derived from marijuana, lessoned seizures in some children with a severe epileptic disorder, according to a double-blind, placebo-controlled study published yesterday (May 25) in the New England Journal of Medicine. The study was sponsored by GW Pharmaceuticals and, as STAT News reported, is the first rigorous study to demonstrate that cannabis components can successfully treat such seizures. Cannabidiol is not psychoactive and thus does not af ..read more

The marijuana-derived compound shows promise in treating rare forms of epilepsy that cause children to have seizures multiple times a day. Cannabidiol, one of dozens of active cannabinoids found in the marijuana plant, can reduce the frequency of seizures in patients suffering from two rare forms of epilepsy called Dravet and Lennox-Gastaut syndromes, according to a study to be presented next week (April 22) at a meeting of the American Academy of Neurology. More than 135 participants, most of whom were children, have completed a 12-week course of a liquid form of the drug, and more than half ..read more

In May, the government of Zimbabwe announced a law that allows farmers to grow and sell cannabis for medical and research purposes. The country becomes only the second in Africa to permit medical marijuana, Lesotho being the first to do so in 2017. The new policy would give researchers in Zimbabwe the ability to conduct their own clinical trials and investigate potential new therapies. And last month, the former minister of Health and Child Care, David Parirenyatwa, told a Zimbabwe Medical Association conference that the government plans to establish a research institute that will position the ..read more

On October 20, marijuana will no longer be an illegal drug in Canada—a move that could make it much easier to study how cannabis affects the body and the brain. Currently in Canada, to study the physiological effects of cannabis in humans, researchers have to apply for an exemption from the Controlled Drugs and Substances Act, which has been difficult to get regardless of the political affiliation of government leaders, Milloy says. Funding hasn’t been easy to come by either, making cannabis research the “poor second cousin of alcohol studies,” notes sociologist Andrew Hathaway of the Universi ..read more

The US Food and Drug Administration today approved for the first time a marijuana-derived drug, Epidiolex, for the treatment of two rare forms of epilepsy. The drug contains cannabidiol, or CBD, and does not make users high while reducing the rate of seizures in patients with Dravet or Lennox-Gastaut syndromes, clinical trials show. “In my practice, I often see patients with these highly treatment-resistant epilepsies who have tried and failed existing therapies and are asking about CBD,” says Orrin Devinsky of NYU Langone Health, a lead investigator in the trials, in a statement released by t ..read more